Yüklüyor......
Esketamine clinical trials: reply to Maju et al.
Maju et al. provided clarifications on important and controversial issues related to esketamine clinical trial data, in response to a vivid debate triggered by the marketing authorisation recently granted by this new medicine. In this commentary, we reply to their comments attempting to critically d...
Kaydedildi:
| Yayımlandı: | Epidemiol Psychiatr Sci |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cambridge University Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214734/ https://ncbi.nlm.nih.gov/pubmed/32345395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S204579602000027X |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|